Home Contact Us
Loading

The American Association of Immunologists

CPA Sessions at IMMUNOLOGY 2009™


Immunology at CDC: Research Opportunities in Public Health

Saturday, May 9, 2009, 12:30 - 2:00 PM

Chair: William R. Green, Dartmouth Medical School, Chair, AAI Committee on Public Affairs


Speakers:

Alison C. Mawle, Associate Director for Laboratory Science, National Center for Immunization and Respiratory Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention
Immunology at CDC: why it matters
Conrad Quinn, Molecular Pathogenesis and Immunology Team, Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention
Anthrax vaccines – from Pasteur to pasture to PA
Ellen Kersh, Laboratory Branch, Pre-clinical Evaluation Team, Division of HIV/AIDS Prevention, National Center for HIV, Hepatitis, STD and TB Prevention, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention
Immunological factors impact susceptibility to SHIV in a macaque model of repeated mucosal viral challenge

Learn about the exciting immunological research being conducted at the CDC. Speakers will also describe ongoing collaborative and interagency work, as well as funding opportunities for scientists. A question and answer period will follow the presentations.


Good Science Gone Bad: "Dual Use" Research and How It Affects You

Sunday, May 10, 2009, 12:30 - 2:30 PM

Chair: William R. Green, Dartmouth Medical School, Chair, AAI Committee on Public Affairs


Keynote Speaker:

Speakers:

David A. Relman, Member, National Science Advisory Board on Biosecurity (NSABB); Professor of Microbiology & Immunology, and of Medicine, Stanford University; Chief of Infectious Diseases, VA Palo Alto Health Care System
The future life sciences landscape: benefits and risks
David R. Franz, Co-Chair, National Science Advisory Board on Biosecurity (NSABB) International Working Group; Chief Biological Scientist, Midwest Research Institute (Frederick, MD)
Regulating "dual-use" research: if the U.S. does, will the world follow?
Paul S. Keim, Chair, National Science Advisory Board on Biosecurity (NSABB) Communications Working Group; Director of Pathogen Genomics, The Translational Research Institute (TGen); Director, Center for Microbial Genetics and Genomics, and The Cowden Endowed Chair in Microbiology. Northern Arizona University, Flagstaff AZ
The anthrax letter attacks: investigating the researchers, investigating the crime

BIOTERRORISM! Caused by a rogue scientist or caused, unknowingly, by you?! Caused by you because you didn't know about "dual use research" (research that can be used for both beneficial and nefarious purposes). This session will explore the political and scientific issues surrounding dual use research, its dangers and benefits — including its forensic role in identifying suspects in the 2002 anthrax case — and many of the key concerns about government regulation of such research. A question and answer period will follow the presentations


Meet the Advocacy Partners

Sunday, May 10, 2009, 4:00 - 5:00 PM

Chair: William R. Green, Dartmouth Medical School, Chair, AAI Committee on Public Affairs


Representatives from the following organizations will be available to talk about their work and about scientific and funding opportunities that may be available to AAI members/meeting attendees:>

  • American Diabetes Association
  • Arthritis Foundation
  • National Alopecia Areata Foundation
  • International Pemphigus & Pemphigoid Foundation

 


Back to Past Sessions Archive

 


© The American Association of Immunologists, Inc.
1451 Rockville Pike, Suite 650 | Rockville, Maryland 20852 | Phone: (301) 634-7178 | Fax: (301) 634-7887
Email: infoaai@aai.org | Website feedback: AAI Webmaster